← FDA DRUG APPROVALS

FDA ANDA · ANDA080727

DIPHENHYDRAMINE HYDROCHLORIDE

Sponsor: HERITAGE PHARMA

APPLICATION
ANDA080727
TYPE
ANDA
ORIGINAL APPROVAL
1972-09-27
LATEST ACTION
1999-10-29
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DIPHENHYDRAMINE HYDROCHLORIDEDiscontinued
DIPHENHYDRAMINE HYDROCHLORIDE 50MG · CAPSULE · ORAL

Approval history

1999-10-29Manufacturing (CMC) · Supplement 46AP
1991-05-31Manufacturing (CMC) · Supplement 43AP
1991-01-28Manufacturing (CMC) · Supplement 44AP
1990-06-29Manufacturing (CMC) · Supplement 42AP
1988-07-21Manufacturing (CMC) · Supplement 40AP
1988-07-21Manufacturing (CMC) · Supplement 39AP
1988-07-21Manufacturing (CMC) · Supplement 41AP
1985-09-11Manufacturing (CMC) · Supplement 36AP
1985-09-11Manufacturing (CMC) · Supplement 35AP
1982-08-04Manufacturing (CMC) · Supplement 31AP
1972-09-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →